Kromek investor relations information
Welcome to the Kromek investor relations section of the Kromek website. Here you will find information on the Group’s latest news and announcements, financial results, annual reports, upcoming events and information to help manage your shareholding.
The information in this section is disclosed in accordance with Rule 26 of the AIM regulations.
Country of incorporation and main country of operation
Kromek Group plc is incorporated in England (Registration Number 8661469). Its main country of operation is the United Kingdom.
Details of exchanges and trading platforms
Kromek securities (EPIC code: KMK) are not listed or traded on any exchanges or trading platforms other than AIM.
Who is Kromek
Kromek is a UK-based platform technology company that provides digital colour x-ray and gamma-ray detection and imaging. Our products enable direct materials identification in the security, civil nuclear and medical markets.
With facilities in the UK and US, Kromek sells internationally with partnerships and distribution channels in Asia, Europe, and North America, to a global customer base ranging from national governments and regulatory bodies to international airports and research institutes, and from major energy providers to the world’s largest technology and medical equipment groups.
Based on innovation in semiconductor production and electronics supported by technologies such as software, algorithms and systems engineering, Kromek has world-leading, often unique capabilities covering the value chain “from semiconductors to solutions”.
Kromek’s portfolio of cutting-edge high-resolution products for gamma-ray detection and isotope analysis in complex nuclear environments differentiate themselves by their sensitivity, high resolution and small form factor allowing unprecedented flexibility in deployment.
In CBRNe security, Kromek offers a range of handheld detectors and within aviation security, the Kromek Identifier liquid explosive detection system (ECAC level 3) brings speedy threat detection that, uniquely, can accurately scan ALL container types, including metal.
We also have a suite of products including Bone Mineral Densitometry (BMD), gamma probes and SPECT, as well as a number of development programmes with partners in the medical CT applications.
The investor relations section of this site was last updated: 9 January 2020.